Pharmaceuticals

Quadrivalent Market Insights: Revenue Expected to Surpass $13.91 Billion by 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the quadrivalent market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Quadrivalent Market?

The quadrivalent market size has seen robust expansion over recent years. Its value is anticipated to rise from $8.87 billion in 2024 to $9.51 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to several factors, including disease complexity, educational initiatives, past health events, healthcare growth, and technological progress.

The quadrivalent market is anticipated to experience robust expansion over the coming years. This market is projected to reach $13.91 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this growth during the forecast period include global health events, competitive dynamics, educational campaigns, regulatory changes, and evolving disease patterns. Key trends anticipated during this period encompass disease prevalence, the regulatory environment, healthcare infrastructure, consumer awareness and education, and the competitive landscape.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

Which Growth Drivers Are Propelling The Quadrivalent Market?

The escalating incidence of chronic and infectious illnesses is projected to fuel the expansion of the quadrivalent market in the coming period. Chronic diseases refer to enduring health conditions stemming from genetic factors and lifestyle choices, while infectious diseases are illnesses resulting from pathogenic agents like viruses, bacteria, fungi, or protozoa. Quadrivalent vaccines play a crucial role in averting severe infections, reducing both illness and fatalities, and also target conditions beyond the specific infections they are designed for. Furthermore, these vaccines are employed in the prevention of chronic (non-communicable) diseases where infectious agents contribute to cancer development. As an illustration, a report from the Centers for Disease Control and Prevention, a US-based non-profit organization, stated that in September 2024, during Week 37, 0.5% of tested specimens showed positive results for influenza, comprising 91.4% influenza A and 8.6% influenza B. Cumulatively, from October 1, 2023 (Week 40), 8.7% of specimens tested positive, with influenza A making up 69.2% and influenza B 30.8%, highlighting an increased overall positivity rate and a greater share of influenza B cases over time. Consequently, the growing occurrence of chronic and infectious diseases is propelling the development of the quadrivalent market.

Which Segmentation Factors Are Most Significant In The Quadrivalent Market Analysis?

The quadrivalent market covered in this report is segmented –

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:

1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery

2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection

3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

What New Opportunities Are Emerging From Trends In The Quadrivalent Market?

Product innovation stands out as a significant trend gaining traction in the quadrivalent market. Prominent companies within the quadrivalent market are dedicated to devising cutting-edge solutions to reinforce their competitive edge. For example, in September 2022, AstraZeneca, a UK-headquartered pharmaceutical company, introduced FluMist quadrivalent (Influenza Vaccination Live, Intranasal). This product is an FDA-approved nasal-spray flu vaccine for individuals aged 2 to 49, which can be given via a needle-free nasal spray. It functions as a live attenuated influenza vaccine (LAIV), available in either trivalent or quadrivalent formulations, and is covered by the majority of health insurance plans, alongside the vaccines for children program.

Who Are The Most Influential Companies In The Quadrivalent Market?

Major companies operating in the quadrivalent market include AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Which Region Holds The Largest Share In The Quadrivalent Market Today?

North America was the largest region in the quadrivalent market in 2024. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9335&type=smp

Browse Through More Reports Similar to the Global Quadrivalent Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795